Clinical trial
BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)
NCT00414284 · Community Research Initiative of New England, Other · Terminated
Key facts
| NCT number | NCT00414284 |
|---|---|
| Title | BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r) |
| Official title | Evaluation of the Pharmacokinetics and Tolerability of Increased Dosage of Lopinavir/Ritonavir(LPV/r) in Individuals Experiencing Viremia on Standard Dose LPV/r Using LPV/r Tablet Formulation |
| Lead sponsor | Community Research Initiative of New England, Other |
| Collaborators | Abbott Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Increased dose of Kaletra |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Dec 21, 2006 |
| Last update posted | Dec 8, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: